AEON Biopharma Awards 392,158 Restricted Stock Units to New Employees Under NYSE American LLC Company Guide Section 711

AEON Biopharma has granted 392,158 restricted stock units to newly hired non-executive employees. The awards were approved by the Company's Board of Directors and have a vesting commencement date of December 2025. The RSUs will vest over four years, with 25% vesting annually. The grants are subject to the terms and conditions of the Inducement Plan and RSU agreement. The awards are being granted as inducement material to new employees entering into employment with the Company.